Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973).

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Anticancer Research

• Publication date

  1993-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8517646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay

  2004cited by this paper
• Phase I trial of FK973: Description of a delayed vascular leak syndrome

  1991cited by this paper
• A new antitumor antibiotic, FK973: its metabolism in the blood and the antitumor effects of its metabolites on experimental models.

  1989cited by this paper
• Precursors in the biosynthesis of FR-900482, a novel antitumor antibiotic produced by Streptomyces sandaensis.

  1988cited by this paper
• Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.

  1988cited by this paper
• A new antitumor antibiotic, FR-900482. III. Antitumor activity in transplantable experimental tumors.

  1987cited by this paper
• A new antitumor antibiotic, FR-900482. II. Production, isolation, characterization and biological activity.

  1987cited by this paper
• ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates.

  1978cited by this paper

• Interstrand cross-linking of DNA by FK317 and its deacetylated metabolites FR70496 and FR157471.

  2003cites this paper
• An in vivo model to study immunotoxin-induced vascular leak in human tissue.

  1999cites this paper
• Vascular leak syndrome: a side effect of immunotherapy.

  1997cites this paper